KennethNg personal page - To The Moon

KennethNg

KennethNg

No personal profile

47Follow

4Followers

0Topic

0Badge

2021-06-14

[Miser]

Biotech Finds Market Love at Last as Meme Traders, FDA Converge

2021-06-13

??

Toplines Before US Market Open on Friday

2021-06-13

??

Moderna Says No Link Between COVID-19 Jab And Heart Inflammation

2021-06-13

??

Urban One Inc Files For Stock Shelf Of Upto $200 Mln Of Class A Common Stock

2021-04-14

$Tiger Brokers(TIGR)$[Heart]

2021-04-09

??

Don't Compare Today's Market With The 2000 Bubble

2021-02-03

??

Market News: Ants reach overhaul agreement with regulators

2021-02-03

??

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3568939926708961","uuid":"3568939926708961","gmtCreate":1605849938380,"gmtModify":1612342617801,"name":"KennethNg","pinyin":"kennethng","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":47,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.18","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.82%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.06%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":182457456,"gmtCreate":1623600952175,"gmtModify":1704206852956,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182457456","repostId":"2142025622","repostType":4,"repost":{"id":"2142025622","kind":"news","pubTimestamp":1623442528,"share":"https://ttm.financial/m/news/2142025622?lang=&edition=fundamental","pubTime":"2021-06-12 04:15","market":"us","language":"en","title":"Biotech Finds Market Love at Last as Meme Traders, FDA Converge","url":"https://stock-news.laohu8.com/highlight/detail?id=2142025622","media":"Bloomberg","summary":"(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial","content":"<p><img src=\"https://static.tigerbbs.com/8cda5e1416d8765a6009019a2442b35a\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. Now investors are taking a second look at the sector.</p>\n<p>With biotech having trailed the broader market for the past three months and chock full of companies that have been the focus of short sellers, it was catnip for the Reddit crowd. Indeed, the price action wrought havoc across the health-care sector after shorts lost over $465 million on Clover Health Investments Corp. in a single day as the stock nearly doubled.</p>\n<p>The moves weren’t just about amateur traders or punishing the shorts. Specialists who live and breathe biotech received two of three critical updates that have been hailed as the impetus for a broad return of investor interest. That includes approval from the Food and Drug Administration of an Alzheimer’s disease drug from Biogen Inc.</p>\n<p>“One of the clouds overhanging the sector went away this week, it’s a very good sign,” Brad Loncar, chief executive officer of Loncar Investments, said of the FDA decision.</p>\n<p>Monday’s decision by the FDA to approve Aduhelm, the first new medicine for the disease in decades, came despite mixed clinical trials, stunning analysts and buoying the sector. More than 15 million shares in the $11 billion <a href=\"https://laohu8.com/S/EEME\">iShares</a> Nasdaq Biotechnology ETF (IBB) changed hands, the highest daily level since June 2017. The index ended the week up 6%.</p>\n<p>It wasn’t all good news for these drugmakers. Aduhelm’s $56,000 a year price tag and a setback for Vertex Pharmaceuticals Inc. tempered the rally. The cost of the Biogen drug renewed concern about a regulatory clampdown on pricing, while Vertex announced that it had halted development of a liver disease treatment that the company said was unlikely to have a clinical benefit for patients. Shares of the drug developer plunged 11% on Friday and it’s the worst performer among large-cap biotechs, falling 18% so far this year.</p>\n<p>There’s <a href=\"https://laohu8.com/S/AONE\">one</a> more key readout biotech investors are waiting on: results from a trial in major depression from Biogen and its partner <a href=\"https://laohu8.com/S/SAGE\">Sage Therapeutics</a> Inc. With a win for Biogen and a loss for Vertex, the Biogen-Sage results could very well determine which direction biotech goes next, according to RBC analyst Brian Abrahams. The data are expected by the end of June.</p>\n<p>A recent Goldman Sachs survey of 75 investors at the bank’s health-care conference highlights the ongoing uncertainty, with 47% saying the sector would outperform over the second half of the year while the rest were evenly split between expecting health stocks to underperform or move in-line with the broader market.</p>\n<p><b>M&amp;A Hopes</b></p>\n<p>Vertex’s recent failure also came with a silver lining: the potential for a deal to bolster its pipeline. “Management has signaled a new openness to later-stage deals, and the shelving of VX-864 may now force its hand,” Bloomberg Intelligence analyst Marc Engelsgjerd wrote in a note.</p>\n<p>The pace of deals in the first half can determine the direction of biotechs for the rest of 2021, with years that start off with five or more deals over $500 million usually driving the outperformance of nearly 4% for the Nasdaq Biotech index, according to JPMorgan’s analysis.</p>\n<p>As biotech specialists weighed the catalysts for further gains, an 86% jump for Chamath Palihapitiya-backed health insurer Clover drove interest toward once high-flying biotechs with highly shorted floats and mediocre analyst ratings. <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals Inc</a>., which recently lost U.S. government funding for its Covid shot, and <a href=\"https://laohu8.com/S/CLVS\">Clovis Oncology</a> Inc., a fallen former M&amp;A target with a disappointing cancer drug, popped this week as day traders targeted short-squeeze candidates.</p>\n<p>Retail traders have also been driving triple-digit and even quadruple-digit gains in obscure biotech names like Ocugen Inc., a drug developer with plans to bring a Covid-19 vaccine to the U.S., and <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>., a 20-year old biotech whose main product isn’t yet in the final stages of testing.</p>\n<p>Loncar at least is unfazed by biotechs joining the meme parade. “Professionals understand what the true intrinsic value of a biotech is,” he said in an interview. “Unlike GameStop or AMC, a biotech either has good science or it doesn’t.”</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biotech Finds Market Love at Last as Meme Traders, FDA Converge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiotech Finds Market Love at Last as Meme Traders, FDA Converge\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 04:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRTX":"福泰制药","BIIB":"渤健公司"},"source_url":"https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142025622","content_text":"(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. Now investors are taking a second look at the sector.\nWith biotech having trailed the broader market for the past three months and chock full of companies that have been the focus of short sellers, it was catnip for the Reddit crowd. Indeed, the price action wrought havoc across the health-care sector after shorts lost over $465 million on Clover Health Investments Corp. in a single day as the stock nearly doubled.\nThe moves weren’t just about amateur traders or punishing the shorts. Specialists who live and breathe biotech received two of three critical updates that have been hailed as the impetus for a broad return of investor interest. That includes approval from the Food and Drug Administration of an Alzheimer’s disease drug from Biogen Inc.\n“One of the clouds overhanging the sector went away this week, it’s a very good sign,” Brad Loncar, chief executive officer of Loncar Investments, said of the FDA decision.\nMonday’s decision by the FDA to approve Aduhelm, the first new medicine for the disease in decades, came despite mixed clinical trials, stunning analysts and buoying the sector. More than 15 million shares in the $11 billion iShares Nasdaq Biotechnology ETF (IBB) changed hands, the highest daily level since June 2017. The index ended the week up 6%.\nIt wasn’t all good news for these drugmakers. Aduhelm’s $56,000 a year price tag and a setback for Vertex Pharmaceuticals Inc. tempered the rally. The cost of the Biogen drug renewed concern about a regulatory clampdown on pricing, while Vertex announced that it had halted development of a liver disease treatment that the company said was unlikely to have a clinical benefit for patients. Shares of the drug developer plunged 11% on Friday and it’s the worst performer among large-cap biotechs, falling 18% so far this year.\nThere’s one more key readout biotech investors are waiting on: results from a trial in major depression from Biogen and its partner Sage Therapeutics Inc. With a win for Biogen and a loss for Vertex, the Biogen-Sage results could very well determine which direction biotech goes next, according to RBC analyst Brian Abrahams. The data are expected by the end of June.\nA recent Goldman Sachs survey of 75 investors at the bank’s health-care conference highlights the ongoing uncertainty, with 47% saying the sector would outperform over the second half of the year while the rest were evenly split between expecting health stocks to underperform or move in-line with the broader market.\nM&A Hopes\nVertex’s recent failure also came with a silver lining: the potential for a deal to bolster its pipeline. “Management has signaled a new openness to later-stage deals, and the shelving of VX-864 may now force its hand,” Bloomberg Intelligence analyst Marc Engelsgjerd wrote in a note.\nThe pace of deals in the first half can determine the direction of biotechs for the rest of 2021, with years that start off with five or more deals over $500 million usually driving the outperformance of nearly 4% for the Nasdaq Biotech index, according to JPMorgan’s analysis.\nAs biotech specialists weighed the catalysts for further gains, an 86% jump for Chamath Palihapitiya-backed health insurer Clover drove interest toward once high-flying biotechs with highly shorted floats and mediocre analyst ratings. Inovio Pharmaceuticals Inc., which recently lost U.S. government funding for its Covid shot, and Clovis Oncology Inc., a fallen former M&A target with a disappointing cancer drug, popped this week as day traders targeted short-squeeze candidates.\nRetail traders have also been driving triple-digit and even quadruple-digit gains in obscure biotech names like Ocugen Inc., a drug developer with plans to bring a Covid-19 vaccine to the U.S., and Cassava Sciences Inc., a 20-year old biotech whose main product isn’t yet in the final stages of testing.\nLoncar at least is unfazed by biotechs joining the meme parade. “Professionals understand what the true intrinsic value of a biotech is,” he said in an interview. “Unlike GameStop or AMC, a biotech either has good science or it doesn’t.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":385,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182402944,"gmtCreate":1623594593988,"gmtModify":1704206756152,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182402944","repostId":"1131879907","repostType":4,"repost":{"id":"1131879907","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623411896,"share":"https://ttm.financial/m/news/1131879907?lang=&edition=fundamental","pubTime":"2021-06-11 19:44","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1131879907","media":"Tiger Newspress","summary":"S&P 500 looks to add to Thursday's record close.\nMeme stocks get some relief after hitting a wall.\nB","content":"<ul>\n <li>S&amp;P 500 looks to add to Thursday's record close.</li>\n <li>Meme stocks get some relief after hitting a wall.</li>\n <li>Blockchain stocks rally in premarket trading.</li>\n <li>Airline stocks rally in premarket trading.</li>\n <li>EV stocks rally in premarket trading.</li>\n</ul>\n<p>(June 11)&nbsp;U.S. stock futures traded slightly higher in early pre-market trade after the S&amp;P 500 index jumped to a new high in the previous session following data on consumer price inflation and jobless claims. Investors are awaiting earnings results from&nbsp;<b>Cheetah Mobile</b>&nbsp;and&nbsp;<b>Azure Power Global</b>.</p>\n<p>The University of Michigan's consumer sentiment index for June is scheduled for release at 10:00 a.m. ET. The consumer sentiment index dropped over 5 points to 82.9 in May due to rising inflation expectations. Analysts, however, expect June's preliminary reading to rise slightly to 84.</p>\n<p>At 7:58 a.m. ET, Dow e-minis were up 73 points, or 0.21%, S&amp;P 500 e-minis were up 6.5 points, or 0.15%, and Nasdaq 100 e-minis were up 28 points, or 0.20%.</p>\n<p><img src=\"https://static.tigerbbs.com/18bcc00946e29ba65e1d29af6ef12226\" tg-width=\"1242\" tg-height=\"507\" referrerpolicy=\"no-referrer\">Meme stocks were getting some relief early Friday after hitting a wall Thursday. Shares of GameStop, which tanked 27% on Thursday, rose 6% in the premarket. GameStop investors seemed to be running for the exits Thursday, one day after the video game retailer announced the appointments of two former Amazon executives as CEO and CFO and said it may sell as many as 5 million additional shares to raise money. GameStop — off about 50% from its $483 per share all-time high in January — remained up nearly 1,100% in 2021. Last week's big winner, AMC Entertainment, rose 4% in Friday's premarket after closing down 13% on Thursday. The stock — down more than 40% from last week's all-time high of $72.62 — was still up 1,900% this year.</p>\n<p><b>Stocks making the biggest moves in the premarket: Snowflake, Vertex Pharmaceuticals, Chewy &amp; more</b></p>\n<p><b>1)&nbsp;Snowflake(SNOW)</b> – Snowflake shares fell 3.7% in premarket trading, following the cloud computing company’s presentation of financial targets at its Investor Day meeting. Snowflake set a target of reaching $10 billion in annual product revenue by 2029, compared to $554 million in its fiscal year that ended in January.</p>\n<p><b>2)&nbsp;Vertex Pharmaceuticals(VRTX)</b> – The drugmaker halted development of an experimental drug designed to treat a rare genetic disease called AAT Deficiency. Vertex said the drug raised levels of a deficient protein, but not enough to provide a substantial benefit. Vertex plunged 13.9% in the premarket.</p>\n<p><b>3)&nbsp;Chewy(CHWY) </b>– Chewy earned 9 cents per share for its latest quarter, compared to consensus forecasts for a 3 cents per share loss. The pet products retailer's revenue also beat estimates and gave an upbeat revenue outlook. Chewy also warned of labor shortages and supply chain issues that are impacting product availability.</p>\n<p><b>4)&nbsp;Dave &amp; Buster's(PLAY) </b>– Dave &amp; Buster's reported a surprise profit for its first quarter, with earnings of 40 cents per share. Analysts had predicted a loss of 16 cents per share for the restaurant chain. Dave &amp; Buster's said the recovery in its business has continued through the first part of the current quarter, and its shares jumped 5.5% in premarket action.</p>\n<p><b>5)&nbsp;Royal Caribbean(RCL)</b> – Royal Caribbean’s Celebrity line said two passengers aboard its Millennium cruise shiptested positive for Covid-19. The passengers – who were traveling together – are asymptomatic and have been isolated, and the cruise line is currently conducting contact tracing. Royal Caribbean lost 1.3% in premarket trading.</p>\n<p><b>6)&nbsp;Biogen(BIIB)</b> – Biogen added 1.4% in the premarket after UBS upgraded the drug maker’s stock to “buy” from “neutral,” and Bernstein raised its rating to “outperform” from “market perform.” Both firms base their upgrades on the potential sales bump from the Food and Drug Administration’s approval this week of Alzheimer’s disease treatment Aduhelm.</p>\n<p><b>7)&nbsp;AMC Entertainment(AMC),GameStop(GME),Clover Health(CLOV)</b> – These “meme stocks” continue to be volatile, with AMC surging 8% in the premarket, GameStop jumping 5.7% and Clover Health up 3%.</p>\n<p><b>8)&nbsp;Tesla(TSLA) </b>– Teslaunveiled its Model S Plaidat an event held at its Fremont, California factory. The new high-end version of its Model S sells for just under $130,000. Separately, Goldman Sachs reiterated its “buy” rating on the stock.</p>\n<p><b>9)&nbsp;American Airlines(AAL)</b> – American Airlines is investing $25 million in electric flying taxi startup Vertical Aerospace. American said it planned to buy up to 250 of the electric aircraft, which are set for an initial test flight later this year.</p>\n<p><b>10)&nbsp;Callaway Golf(ELY)</b> – Callaway Golf will replaceGrubHub(GRUB) in the S&amp;P MidCap 400 index, effective prior to the opening of trading on June 15. GrubHub is in the process of being acquired by British firm Just Eat Takeaway. Callaway – a leading maker of golf clubs and other golf products – will be replaced in the S&amp;P SmallCap 600 byApollo Medical(AMEH). Callaway slid 3.7% in premarket trading, while Apollo surged 11.9%.</p>\n<p><b>11)&nbsp;Livent(LTHM)</b> – The lithium power specialist’s shares fell 2% in the premarket after announcing a public offering of 13 million shares at $17.50 per share. Livent plans to use the proceeds for general corporate purposes, repaying debt, and boosting capital spending.</p>\n<p><b>12)&nbsp;Monday.com(MNDY)</b> – The Israel-based maker of work management software is on watch ahead of its second day of trading, after pricing its initial public offering at $155 per share and closing Thursday at $178.87.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-11 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>S&amp;P 500 looks to add to Thursday's record close.</li>\n <li>Meme stocks get some relief after hitting a wall.</li>\n <li>Blockchain stocks rally in premarket trading.</li>\n <li>Airline stocks rally in premarket trading.</li>\n <li>EV stocks rally in premarket trading.</li>\n</ul>\n<p>(June 11)&nbsp;U.S. stock futures traded slightly higher in early pre-market trade after the S&amp;P 500 index jumped to a new high in the previous session following data on consumer price inflation and jobless claims. Investors are awaiting earnings results from&nbsp;<b>Cheetah Mobile</b>&nbsp;and&nbsp;<b>Azure Power Global</b>.</p>\n<p>The University of Michigan's consumer sentiment index for June is scheduled for release at 10:00 a.m. ET. The consumer sentiment index dropped over 5 points to 82.9 in May due to rising inflation expectations. Analysts, however, expect June's preliminary reading to rise slightly to 84.</p>\n<p>At 7:58 a.m. ET, Dow e-minis were up 73 points, or 0.21%, S&amp;P 500 e-minis were up 6.5 points, or 0.15%, and Nasdaq 100 e-minis were up 28 points, or 0.20%.</p>\n<p><img src=\"https://static.tigerbbs.com/18bcc00946e29ba65e1d29af6ef12226\" tg-width=\"1242\" tg-height=\"507\" referrerpolicy=\"no-referrer\">Meme stocks were getting some relief early Friday after hitting a wall Thursday. Shares of GameStop, which tanked 27% on Thursday, rose 6% in the premarket. GameStop investors seemed to be running for the exits Thursday, one day after the video game retailer announced the appointments of two former Amazon executives as CEO and CFO and said it may sell as many as 5 million additional shares to raise money. GameStop — off about 50% from its $483 per share all-time high in January — remained up nearly 1,100% in 2021. Last week's big winner, AMC Entertainment, rose 4% in Friday's premarket after closing down 13% on Thursday. The stock — down more than 40% from last week's all-time high of $72.62 — was still up 1,900% this year.</p>\n<p><b>Stocks making the biggest moves in the premarket: Snowflake, Vertex Pharmaceuticals, Chewy &amp; more</b></p>\n<p><b>1)&nbsp;Snowflake(SNOW)</b> – Snowflake shares fell 3.7% in premarket trading, following the cloud computing company’s presentation of financial targets at its Investor Day meeting. Snowflake set a target of reaching $10 billion in annual product revenue by 2029, compared to $554 million in its fiscal year that ended in January.</p>\n<p><b>2)&nbsp;Vertex Pharmaceuticals(VRTX)</b> – The drugmaker halted development of an experimental drug designed to treat a rare genetic disease called AAT Deficiency. Vertex said the drug raised levels of a deficient protein, but not enough to provide a substantial benefit. Vertex plunged 13.9% in the premarket.</p>\n<p><b>3)&nbsp;Chewy(CHWY) </b>– Chewy earned 9 cents per share for its latest quarter, compared to consensus forecasts for a 3 cents per share loss. The pet products retailer's revenue also beat estimates and gave an upbeat revenue outlook. Chewy also warned of labor shortages and supply chain issues that are impacting product availability.</p>\n<p><b>4)&nbsp;Dave &amp; Buster's(PLAY) </b>– Dave &amp; Buster's reported a surprise profit for its first quarter, with earnings of 40 cents per share. Analysts had predicted a loss of 16 cents per share for the restaurant chain. Dave &amp; Buster's said the recovery in its business has continued through the first part of the current quarter, and its shares jumped 5.5% in premarket action.</p>\n<p><b>5)&nbsp;Royal Caribbean(RCL)</b> – Royal Caribbean’s Celebrity line said two passengers aboard its Millennium cruise shiptested positive for Covid-19. The passengers – who were traveling together – are asymptomatic and have been isolated, and the cruise line is currently conducting contact tracing. Royal Caribbean lost 1.3% in premarket trading.</p>\n<p><b>6)&nbsp;Biogen(BIIB)</b> – Biogen added 1.4% in the premarket after UBS upgraded the drug maker’s stock to “buy” from “neutral,” and Bernstein raised its rating to “outperform” from “market perform.” Both firms base their upgrades on the potential sales bump from the Food and Drug Administration’s approval this week of Alzheimer’s disease treatment Aduhelm.</p>\n<p><b>7)&nbsp;AMC Entertainment(AMC),GameStop(GME),Clover Health(CLOV)</b> – These “meme stocks” continue to be volatile, with AMC surging 8% in the premarket, GameStop jumping 5.7% and Clover Health up 3%.</p>\n<p><b>8)&nbsp;Tesla(TSLA) </b>– Teslaunveiled its Model S Plaidat an event held at its Fremont, California factory. The new high-end version of its Model S sells for just under $130,000. Separately, Goldman Sachs reiterated its “buy” rating on the stock.</p>\n<p><b>9)&nbsp;American Airlines(AAL)</b> – American Airlines is investing $25 million in electric flying taxi startup Vertical Aerospace. American said it planned to buy up to 250 of the electric aircraft, which are set for an initial test flight later this year.</p>\n<p><b>10)&nbsp;Callaway Golf(ELY)</b> – Callaway Golf will replaceGrubHub(GRUB) in the S&amp;P MidCap 400 index, effective prior to the opening of trading on June 15. GrubHub is in the process of being acquired by British firm Just Eat Takeaway. Callaway – a leading maker of golf clubs and other golf products – will be replaced in the S&amp;P SmallCap 600 byApollo Medical(AMEH). Callaway slid 3.7% in premarket trading, while Apollo surged 11.9%.</p>\n<p><b>11)&nbsp;Livent(LTHM)</b> – The lithium power specialist’s shares fell 2% in the premarket after announcing a public offering of 13 million shares at $17.50 per share. Livent plans to use the proceeds for general corporate purposes, repaying debt, and boosting capital spending.</p>\n<p><b>12)&nbsp;Monday.com(MNDY)</b> – The Israel-based maker of work management software is on watch ahead of its second day of trading, after pricing its initial public offering at $155 per share and closing Thursday at $178.87.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131879907","content_text":"S&P 500 looks to add to Thursday's record close.\nMeme stocks get some relief after hitting a wall.\nBlockchain stocks rally in premarket trading.\nAirline stocks rally in premarket trading.\nEV stocks rally in premarket trading.\n\n(June 11) U.S. stock futures traded slightly higher in early pre-market trade after the S&P 500 index jumped to a new high in the previous session following data on consumer price inflation and jobless claims. Investors are awaiting earnings results from Cheetah Mobile and Azure Power Global.\nThe University of Michigan's consumer sentiment index for June is scheduled for release at 10:00 a.m. ET. The consumer sentiment index dropped over 5 points to 82.9 in May due to rising inflation expectations. Analysts, however, expect June's preliminary reading to rise slightly to 84.\nAt 7:58 a.m. ET, Dow e-minis were up 73 points, or 0.21%, S&P 500 e-minis were up 6.5 points, or 0.15%, and Nasdaq 100 e-minis were up 28 points, or 0.20%.\nMeme stocks were getting some relief early Friday after hitting a wall Thursday. Shares of GameStop, which tanked 27% on Thursday, rose 6% in the premarket. GameStop investors seemed to be running for the exits Thursday, one day after the video game retailer announced the appointments of two former Amazon executives as CEO and CFO and said it may sell as many as 5 million additional shares to raise money. GameStop — off about 50% from its $483 per share all-time high in January — remained up nearly 1,100% in 2021. Last week's big winner, AMC Entertainment, rose 4% in Friday's premarket after closing down 13% on Thursday. The stock — down more than 40% from last week's all-time high of $72.62 — was still up 1,900% this year.\nStocks making the biggest moves in the premarket: Snowflake, Vertex Pharmaceuticals, Chewy & more\n1) Snowflake(SNOW) – Snowflake shares fell 3.7% in premarket trading, following the cloud computing company’s presentation of financial targets at its Investor Day meeting. Snowflake set a target of reaching $10 billion in annual product revenue by 2029, compared to $554 million in its fiscal year that ended in January.\n2) Vertex Pharmaceuticals(VRTX) – The drugmaker halted development of an experimental drug designed to treat a rare genetic disease called AAT Deficiency. Vertex said the drug raised levels of a deficient protein, but not enough to provide a substantial benefit. Vertex plunged 13.9% in the premarket.\n3) Chewy(CHWY) – Chewy earned 9 cents per share for its latest quarter, compared to consensus forecasts for a 3 cents per share loss. The pet products retailer's revenue also beat estimates and gave an upbeat revenue outlook. Chewy also warned of labor shortages and supply chain issues that are impacting product availability.\n4) Dave & Buster's(PLAY) – Dave & Buster's reported a surprise profit for its first quarter, with earnings of 40 cents per share. Analysts had predicted a loss of 16 cents per share for the restaurant chain. Dave & Buster's said the recovery in its business has continued through the first part of the current quarter, and its shares jumped 5.5% in premarket action.\n5) Royal Caribbean(RCL) – Royal Caribbean’s Celebrity line said two passengers aboard its Millennium cruise shiptested positive for Covid-19. The passengers – who were traveling together – are asymptomatic and have been isolated, and the cruise line is currently conducting contact tracing. Royal Caribbean lost 1.3% in premarket trading.\n6) Biogen(BIIB) – Biogen added 1.4% in the premarket after UBS upgraded the drug maker’s stock to “buy” from “neutral,” and Bernstein raised its rating to “outperform” from “market perform.” Both firms base their upgrades on the potential sales bump from the Food and Drug Administration’s approval this week of Alzheimer’s disease treatment Aduhelm.\n7) AMC Entertainment(AMC),GameStop(GME),Clover Health(CLOV) – These “meme stocks” continue to be volatile, with AMC surging 8% in the premarket, GameStop jumping 5.7% and Clover Health up 3%.\n8) Tesla(TSLA) – Teslaunveiled its Model S Plaidat an event held at its Fremont, California factory. The new high-end version of its Model S sells for just under $130,000. Separately, Goldman Sachs reiterated its “buy” rating on the stock.\n9) American Airlines(AAL) – American Airlines is investing $25 million in electric flying taxi startup Vertical Aerospace. American said it planned to buy up to 250 of the electric aircraft, which are set for an initial test flight later this year.\n10) Callaway Golf(ELY) – Callaway Golf will replaceGrubHub(GRUB) in the S&P MidCap 400 index, effective prior to the opening of trading on June 15. GrubHub is in the process of being acquired by British firm Just Eat Takeaway. Callaway – a leading maker of golf clubs and other golf products – will be replaced in the S&P SmallCap 600 byApollo Medical(AMEH). Callaway slid 3.7% in premarket trading, while Apollo surged 11.9%.\n11) Livent(LTHM) – The lithium power specialist’s shares fell 2% in the premarket after announcing a public offering of 13 million shares at $17.50 per share. Livent plans to use the proceeds for general corporate purposes, repaying debt, and boosting capital spending.\n12) Monday.com(MNDY) – The Israel-based maker of work management software is on watch ahead of its second day of trading, after pricing its initial public offering at $155 per share and closing Thursday at $178.87.","news_type":1},"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182408995,"gmtCreate":1623594402017,"gmtModify":1704206754370,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182408995","repostId":"2142024122","repostType":4,"repost":{"id":"2142024122","kind":"news","pubTimestamp":1623437876,"share":"https://ttm.financial/m/news/2142024122?lang=&edition=fundamental","pubTime":"2021-06-12 02:57","market":"us","language":"en","title":"Moderna Says No Link Between COVID-19 Jab And Heart Inflammation","url":"https://stock-news.laohu8.com/highlight/detail?id=2142024122","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and ca","content":"<p><img src=\"https://static.tigerbbs.com/d1f671326f56d69d77095c4224c4a60a\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis,&nbsp;based on a review of safety data.</p>\n<p>The Centers for Disease Control and Prevention (CDC) has identified 216 cases of heart inflammation after the first dose of an mRNA shot and another 573 cases after the second dose,&nbsp;Bloomberg reported.</p>\n<p>The median age of people with myocarditis or pericarditis following the first dose was 30 and 24 in the second-dose cases. There were 475 cases among people under 30.</p>\n<p>U.S. public health advisers will meet later this month to discuss a potential link between messenger RNA technology-based COVID-19 shots and heart inflammation.</p>\n<p>The technology is used by Moderna’s vaccine and&nbsp;<b>Pfizer Inc&nbsp;</b>(NYSE: PFE) -&nbsp;<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;</b>(NASDAQ: BNTX).</p>\n<p>Moderna said it “will continue to monitor these reports closely and is actively working with public health and regulatory authorities to further assess this issue.”</p>\n<p>Earlier this month,&nbsp;Israel’s Health Ministry also reportedly found&nbsp;a small number of heart inflammation cases, observed mainly in young men who received the Pfizer COVID-19 vaccine in Israel, were likely linked to their vaccination.</p>\n<p><b>Price Action:</b>&nbsp;MRNA shares are down 0.59% at $215.73 during the market session on the last check Friday.</p>\n<p></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Says No Link Between COVID-19 Jab And Heart Inflammation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Says No Link Between COVID-19 Jab And Heart Inflammation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 02:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-says-no-between-covid-185756853.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis, based on a review of safety data.\nThe Centers for Disease ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-says-no-between-covid-185756853.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","08237":"华星控股"},"source_url":"https://finance.yahoo.com/news/moderna-says-no-between-covid-185756853.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142024122","content_text":"Moderna Inc (NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis, based on a review of safety data.\nThe Centers for Disease Control and Prevention (CDC) has identified 216 cases of heart inflammation after the first dose of an mRNA shot and another 573 cases after the second dose, Bloomberg reported.\nThe median age of people with myocarditis or pericarditis following the first dose was 30 and 24 in the second-dose cases. There were 475 cases among people under 30.\nU.S. public health advisers will meet later this month to discuss a potential link between messenger RNA technology-based COVID-19 shots and heart inflammation.\nThe technology is used by Moderna’s vaccine and Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX).\nModerna said it “will continue to monitor these reports closely and is actively working with public health and regulatory authorities to further assess this issue.”\nEarlier this month, Israel’s Health Ministry also reportedly found a small number of heart inflammation cases, observed mainly in young men who received the Pfizer COVID-19 vaccine in Israel, were likely linked to their vaccination.\nPrice Action: MRNA shares are down 0.59% at $215.73 during the market session on the last check Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182401763,"gmtCreate":1623594378352,"gmtModify":1704206754046,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182401763","repostId":"2142202519","repostType":4,"repost":{"id":"2142202519","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1623444364,"share":"https://ttm.financial/m/news/2142202519?lang=&edition=fundamental","pubTime":"2021-06-12 04:46","market":"hk","language":"en","title":"Urban One Inc Files For Stock Shelf Of Upto $200 Mln Of Class A Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2142202519","media":"T-Reuters","summary":"Urban One Inc:Urban One Inc Files For Stock Shelf Of Upto $200 Million Of Class A Common Stock - Sec","content":"<p>Urban One Inc:Urban One Inc Files For Stock Shelf Of Upto $200 Million Of Class A Common Stock - Sec Filing.Further Company Coverage: Uonek.O. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Urban One Inc Files For Stock Shelf Of Upto $200 Mln Of Class A Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUrban One Inc Files For Stock Shelf Of Upto $200 Mln Of Class A Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-06-12 04:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Urban One Inc:Urban One Inc Files For Stock Shelf Of Upto $200 Million Of Class A Common Stock - Sec Filing.Further Company Coverage: Uonek.O. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGEM":"Cullinan Therapeutics","APR":"Apria, Inc.","UONEK":"Urban One Inc","LABP":"Landos Biopharma, Inc.","LHDX":"Lucira Health, Inc.","SANA":"Sana Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142202519","content_text":"Urban One Inc:Urban One Inc Files For Stock Shelf Of Upto $200 Million Of Class A Common Stock - Sec Filing.Further Company Coverage: Uonek.O. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1},"isVote":1,"tweetType":1,"viewCount":274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":344511137,"gmtCreate":1618414768929,"gmtModify":1704710563027,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Heart]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Heart]&nbsp;","text":"$Tiger Brokers(TIGR)$[Heart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344511137","isVote":1,"tweetType":1,"viewCount":586,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":348806858,"gmtCreate":1617899269374,"gmtModify":1704704634850,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348806858","repostId":"1162076415","repostType":4,"repost":{"id":"1162076415","kind":"news","pubTimestamp":1617894723,"share":"https://ttm.financial/m/news/1162076415?lang=&edition=fundamental","pubTime":"2021-04-08 23:12","market":"us","language":"en","title":"Don't Compare Today's Market With The 2000 Bubble","url":"https://stock-news.laohu8.com/highlight/detail?id=1162076415","media":"seekingalpha","summary":"The 2000 bubble was about expectations about the future payoffs.The current stock market environment is a political economy bubble.Don't expect an imminent stock market crash now .Many market commentators are comparing the current stock market environment with the 2000 bubble. When you look at the S&P 500  valuations based on the CAPE Ratio , the stock market is almost as overvalued now as it was in 2000 at the peak of the dot.com bubble. So, it's understandable that many are drawing the compari","content":"<p><b>Summary</b></p>\n<ul>\n <li>The 2000 bubble was about expectations about the future payoffs.</li>\n <li>The current stock market environment is a political economy bubble.</li>\n <li>Don't expect an imminent stock market crash now (like in March of 2000).</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/afa0d9782d5f36404e2dc19a1ab2ea64\" tg-width=\"1536\" tg-height=\"884\"><span>Photo by anankkml/iStock via Getty Images</span></p>\n<p>Many market&nbsp;commentators&nbsp;are comparing the current stock market environment with the 2000 bubble. When you look at the S&amp;P 500 (SPY) valuations based on the CAPE Ratio (as shown in the chat below), the stock market is almost as overvalued now as it was in 2000 at the peak of the dot.com bubble. So, it's understandable that many are drawing the comparisons - the current CAPE ratio at nearly 37 is the second highest in history, just below the 45 level in 2000. The CAPE ratio is looking at 10 years of inflation-adjusted earnings in relation to the price. The average CAPE ratio is around 16.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3d86193efce2e067ea4c08b06b05eb8e\" tg-width=\"640\" tg-height=\"276\"><span>Source: Shiller PE Ratio (multpl.com)</span></p>\n<p></p>\n<p>However, the current stock market environment is very different when compared to the environment in 2000, and thus, I don't see an imminent stock market crash - like in 2000. In fact, the current stock market bubble can continue to inflate for long time.</p>\n<p><b>The 2000 bubble</b></p>\n<p>I worked on Wall Street in mid-1990, before starting a Ph.D. program where I wrote the dissertation on the dot.com bubble (part 1,part 2). So, based on my experience and research this is what happened in 2000:</p>\n<ul>\n <li><b>Dot.coms valued as lottery tickets.</b>There was a general understanding that we were entering \"the new economy\", where physical mortar and brick stores would eventually be replaced with on-line stores, our social lives would be moved to \"chatrooms\", etc. There were many companies trying to take the market share (in different segments) of what was perceived as an enormous market opportunity. We just didn't know which companies would take the lead and win the race. So, investors looked at each dot.com as a lottery ticket - where the payoff from the winner would be huge. Here is the example of the winner: Amazon (AMZN) - the winning lottery ticket.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/0563c290a95ccca8eb26e5fe85a92209\" tg-width=\"635\" tg-height=\"403\"><span>Data by YCharts</span></p>\n<ul>\n <li><b>The new economy and rational expectations</b>: Clearly, when you value a company as a lottery ticket, you ignore the current fundamentals and focus on the probability of future payoff. As a result, investors were biding the prices higher ignoring the earnings - most dot.coms had no profits and just modest revenues. Thus, the valuations, such as CAPE, were extremely overvalued - which is clearly irrelevant when you value a company more as a real option. Now we know, expectations in the mid-1990s were rational as our lives are currently deep into the digital economy, and there are clear winners.</li>\n <li><b>The Fed and irrational exuberance:</b>The Fed, led by Greenspan, acknowledged that there was \"irrational exuberance\" with respect to valuation of dot.coms in mid 1990's, but failed to act to restrain the bubble early. The problem with bubbles is that many individual investors get involved, speculate, and lose their savings, which could cause a systematic event by spreading to other sectors of economy. Thus, near the peak of the speculative bubble, the Fed did increase interest rates and invert the yield curve in February of 2000, which popped the bubble and eventually caused the recession of 2001, as shown below.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/056dc2123371133c60c9f78dbe7341ee\" tg-width=\"640\" tg-height=\"247\"></p>\n<p><b>The 2021 Bubble</b></p>\n<p>So let's be consistent and call the current market environment a bubble - strictly on valuation basis. However, the current environment is much different compared to the 2000 bubble. Here is how:</p>\n<ul>\n <li><b>Political economy bubble:</b>The stock market has been hijacked by the politics, which could traced to the 2008 US election, when the stock market crash contributed to the Obama victory. The Obama administration run the election on left-platform, but moved to the center in March of 2009 with the Wall Street bailout, which marked the bottom of the stock market crash, and commenced the bull marked still in place today - if you ignore the short pandemic shock in 2020. In fact, the Trump administration publicly embraced the stock market as the barometer of policies in place and cheered the each successive record market close. It's still early in the Biden administration, but Biden clearly run as a centrist and, obviously, the fiscal spending programs will ultimately end up on corporate income statements.</li>\n <li><b>The Fed independence in question</b>: As previously explained, the 2000 bubble was ultimately popped by the Fed. Now, the Fed publicly justifies the bubble-like valuations as irrelevant when compared to low interest rates - the TINA argument promoted by the Fed (there is no alternative to stocks). Fed Chair Powell tried to increase the interest rates in 2019, but quickly reversed the policy and lowered the interest rates after the sharp stock market correction. Now, the Fed basically guarantees the near-zero percent interest rates indefinitely as long as inflation does not significantly exceed 2% for some time. Note, the yield curve was inverted in 2000, and now it's approaching positive the 2% level. Stocks don't crash in this type of macro environment.</li>\n</ul>\n<p><b>Implications for investors</b></p>\n<p>The 2000 bubble was all about expectations about future pay-off from the digital economy, which were rational as we now know, but got out of hand somewhat. The Fed prudently popped the bubble. The current market environment is based primarily on the political economy: election cycles and intertwined fiscal and monetary policy. Thus, this bubble can continue to inflate for some time.</p>\n<p>However, there are segments in the current market that resemble the 2000 environment, most notably the EV market. Companies like Tesla (TSLA) command high valuations based on expectations on exponential growth in the EV market, and investors are trying to pick the winners. This segment is vulnerable to sharp correction - and some companies might not survive.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don't Compare Today's Market With The 2000 Bubble</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon't Compare Today's Market With The 2000 Bubble\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-08 23:12 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4418159-dont-compare-todays-market-2000-bubble><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe 2000 bubble was about expectations about the future payoffs.\nThe current stock market environment is a political economy bubble.\nDon't expect an imminent stock market crash now (like in ...</p>\n\n<a href=\"https://seekingalpha.com/article/4418159-dont-compare-todays-market-2000-bubble\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://seekingalpha.com/article/4418159-dont-compare-todays-market-2000-bubble","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1162076415","content_text":"Summary\n\nThe 2000 bubble was about expectations about the future payoffs.\nThe current stock market environment is a political economy bubble.\nDon't expect an imminent stock market crash now (like in March of 2000).\n\nPhoto by anankkml/iStock via Getty Images\nMany market commentators are comparing the current stock market environment with the 2000 bubble. When you look at the S&P 500 (SPY) valuations based on the CAPE Ratio (as shown in the chat below), the stock market is almost as overvalued now as it was in 2000 at the peak of the dot.com bubble. So, it's understandable that many are drawing the comparisons - the current CAPE ratio at nearly 37 is the second highest in history, just below the 45 level in 2000. The CAPE ratio is looking at 10 years of inflation-adjusted earnings in relation to the price. The average CAPE ratio is around 16.\nSource: Shiller PE Ratio (multpl.com)\n\nHowever, the current stock market environment is very different when compared to the environment in 2000, and thus, I don't see an imminent stock market crash - like in 2000. In fact, the current stock market bubble can continue to inflate for long time.\nThe 2000 bubble\nI worked on Wall Street in mid-1990, before starting a Ph.D. program where I wrote the dissertation on the dot.com bubble (part 1,part 2). So, based on my experience and research this is what happened in 2000:\n\nDot.coms valued as lottery tickets.There was a general understanding that we were entering \"the new economy\", where physical mortar and brick stores would eventually be replaced with on-line stores, our social lives would be moved to \"chatrooms\", etc. There were many companies trying to take the market share (in different segments) of what was perceived as an enormous market opportunity. We just didn't know which companies would take the lead and win the race. So, investors looked at each dot.com as a lottery ticket - where the payoff from the winner would be huge. Here is the example of the winner: Amazon (AMZN) - the winning lottery ticket.\n\nData by YCharts\n\nThe new economy and rational expectations: Clearly, when you value a company as a lottery ticket, you ignore the current fundamentals and focus on the probability of future payoff. As a result, investors were biding the prices higher ignoring the earnings - most dot.coms had no profits and just modest revenues. Thus, the valuations, such as CAPE, were extremely overvalued - which is clearly irrelevant when you value a company more as a real option. Now we know, expectations in the mid-1990s were rational as our lives are currently deep into the digital economy, and there are clear winners.\nThe Fed and irrational exuberance:The Fed, led by Greenspan, acknowledged that there was \"irrational exuberance\" with respect to valuation of dot.coms in mid 1990's, but failed to act to restrain the bubble early. The problem with bubbles is that many individual investors get involved, speculate, and lose their savings, which could cause a systematic event by spreading to other sectors of economy. Thus, near the peak of the speculative bubble, the Fed did increase interest rates and invert the yield curve in February of 2000, which popped the bubble and eventually caused the recession of 2001, as shown below.\n\n\nThe 2021 Bubble\nSo let's be consistent and call the current market environment a bubble - strictly on valuation basis. However, the current environment is much different compared to the 2000 bubble. Here is how:\n\nPolitical economy bubble:The stock market has been hijacked by the politics, which could traced to the 2008 US election, when the stock market crash contributed to the Obama victory. The Obama administration run the election on left-platform, but moved to the center in March of 2009 with the Wall Street bailout, which marked the bottom of the stock market crash, and commenced the bull marked still in place today - if you ignore the short pandemic shock in 2020. In fact, the Trump administration publicly embraced the stock market as the barometer of policies in place and cheered the each successive record market close. It's still early in the Biden administration, but Biden clearly run as a centrist and, obviously, the fiscal spending programs will ultimately end up on corporate income statements.\nThe Fed independence in question: As previously explained, the 2000 bubble was ultimately popped by the Fed. Now, the Fed publicly justifies the bubble-like valuations as irrelevant when compared to low interest rates - the TINA argument promoted by the Fed (there is no alternative to stocks). Fed Chair Powell tried to increase the interest rates in 2019, but quickly reversed the policy and lowered the interest rates after the sharp stock market correction. Now, the Fed basically guarantees the near-zero percent interest rates indefinitely as long as inflation does not significantly exceed 2% for some time. Note, the yield curve was inverted in 2000, and now it's approaching positive the 2% level. Stocks don't crash in this type of macro environment.\n\nImplications for investors\nThe 2000 bubble was all about expectations about future pay-off from the digital economy, which were rational as we now know, but got out of hand somewhat. The Fed prudently popped the bubble. The current market environment is based primarily on the political economy: election cycles and intertwined fiscal and monetary policy. Thus, this bubble can continue to inflate for some time.\nHowever, there are segments in the current market that resemble the 2000 environment, most notably the EV market. Companies like Tesla (TSLA) command high valuations based on expectations on exponential growth in the EV market, and investors are trying to pick the winners. This segment is vulnerable to sharp correction - and some companies might not survive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314683216,"gmtCreate":1612344410635,"gmtModify":1704869948663,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/314683216","repostId":"2108570747","repostType":2,"repost":{"id":"2108570747","kind":"news","pubTimestamp":1612344121,"share":"https://ttm.financial/m/news/2108570747?lang=&edition=fundamental","pubTime":"2021-02-03 17:22","market":"us","language":"en","title":"Market News: Ants reach overhaul agreement with regulators","url":"https://stock-news.laohu8.com/highlight/detail?id=2108570747","media":"Bloomberg","summary":"(Bloomberg) -- Ant Group Co. and Chinese regulators have agreed on a restructuring plan that will tu","content":"<p>(Bloomberg) -- Ant Group Co. and Chinese regulators have agreed on a restructuring plan that will turn Jack Ma’s fintech giant into a financial holding company, making it subject to capital requirements similar to those for banks.</p>\n<p>The plan calls for putting all of Ant’s businesses into the holding company, including its technology offerings in areas like blockchain and food delivery, people familiar with the matter said. One of Ant’s early proposals to regulators had envisioned putting only financial operations into the new structure.</p>\n<p>An official announcement on the overhaul could come before the start of China’s Lunar New Year holiday next week, the people said, asking not to be identified discussing private information. Alibaba Group Holding Ltd., which owns about a third of Ant, erased losses in Hong Kong trading on Wednesday after Bloomberg reported the agreement. The stock closed with a 0.4% gain.</p>\n<p>Ant’s restructuring plan marks the first big step in what’s expected to be a lengthy overhaul process, as regulators draw up detailed capital requirements and other guidelines for companies that span multiple financial business lines.</p>\n<p>China only introduced its framework for financial holding companies in September and many of the specifics are still being ironed out. While the rules will eventually provide more regulatory clarity for Ant, they’ll almost certainly force the company to slow the torrid pace of expansion that has made it China’s dominant fintech player and <a href=\"https://laohu8.com/S/AONE\">one</a> of the world’s most valuable startups.</p>\n<p>Ant is still exploring possibilities to revive its initial public offering, which was abruptly halted by regulators in November, <a href=\"https://laohu8.com/S/AONE.U\">one</a> person familiar with the matter said. But given the financial holding company framework is so new, it’s unclear how long it might take for authorities to sign off a listing.</p>\n<p>Ant declined to comment. The People’s Bank of China, which oversees financial holding companies, didn’t immediately respond to a faxed request for comment.</p>\n<p>Ant’s restructuring is part of a broader government campaign to increase supervision of the financial and technology sectors. Regulators have in recent months targeted everything from health-care crowdfunding to consumer lending. In January, they proposed measures to curb market concentration in online payments, where Ant and Tencent Holdings Ltd. are the biggest players.</p>\n<p>The clampdown has fueled intense speculation over the status of Ma, who co-founded both Ant and Alibaba. The e-commerce giant has also faced increased government scrutiny in recent months, becoming the target of an antitrust investigation in December.</p>\n<p>Ma’s appearance in a live-streamed video conference in January -- after several months out of public view -- has helped quell talk of worst-case scenarios for his business empire. Still, plenty of uncertainty remains: even after Wednesday’s gain, Alibaba’s Hong Kong shares are trading about 15% below their record high in October.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Market News: Ants reach overhaul agreement with regulators</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMarket News: Ants reach overhaul agreement with regulators\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-03 17:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ant-reaches-agreement-china-regulators-083830972.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Ant Group Co. and Chinese regulators have agreed on a restructuring plan that will turn Jack Ma’s fintech giant into a financial holding company, making it subject to capital ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ant-reaches-agreement-china-regulators-083830972.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/9a353fd7027b404fd0462b771be77661","relate_stocks":{"BABA":"阿里巴巴","09988":"阿里巴巴-W"},"source_url":"https://finance.yahoo.com/news/ant-reaches-agreement-china-regulators-083830972.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108570747","content_text":"(Bloomberg) -- Ant Group Co. and Chinese regulators have agreed on a restructuring plan that will turn Jack Ma’s fintech giant into a financial holding company, making it subject to capital requirements similar to those for banks.\nThe plan calls for putting all of Ant’s businesses into the holding company, including its technology offerings in areas like blockchain and food delivery, people familiar with the matter said. One of Ant’s early proposals to regulators had envisioned putting only financial operations into the new structure.\nAn official announcement on the overhaul could come before the start of China’s Lunar New Year holiday next week, the people said, asking not to be identified discussing private information. Alibaba Group Holding Ltd., which owns about a third of Ant, erased losses in Hong Kong trading on Wednesday after Bloomberg reported the agreement. The stock closed with a 0.4% gain.\nAnt’s restructuring plan marks the first big step in what’s expected to be a lengthy overhaul process, as regulators draw up detailed capital requirements and other guidelines for companies that span multiple financial business lines.\nChina only introduced its framework for financial holding companies in September and many of the specifics are still being ironed out. While the rules will eventually provide more regulatory clarity for Ant, they’ll almost certainly force the company to slow the torrid pace of expansion that has made it China’s dominant fintech player and one of the world’s most valuable startups.\nAnt is still exploring possibilities to revive its initial public offering, which was abruptly halted by regulators in November, one person familiar with the matter said. But given the financial holding company framework is so new, it’s unclear how long it might take for authorities to sign off a listing.\nAnt declined to comment. The People’s Bank of China, which oversees financial holding companies, didn’t immediately respond to a faxed request for comment.\nAnt’s restructuring is part of a broader government campaign to increase supervision of the financial and technology sectors. Regulators have in recent months targeted everything from health-care crowdfunding to consumer lending. In January, they proposed measures to curb market concentration in online payments, where Ant and Tencent Holdings Ltd. are the biggest players.\nThe clampdown has fueled intense speculation over the status of Ma, who co-founded both Ant and Alibaba. The e-commerce giant has also faced increased government scrutiny in recent months, becoming the target of an antitrust investigation in December.\nMa’s appearance in a live-streamed video conference in January -- after several months out of public view -- has helped quell talk of worst-case scenarios for his business empire. Still, plenty of uncertainty remains: even after Wednesday’s gain, Alibaba’s Hong Kong shares are trading about 15% below their record high in October.","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314696917,"gmtCreate":1612341635839,"gmtModify":1704869911242,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/314696917","repostId":"1163068052","repostType":2,"isVote":1,"tweetType":1,"viewCount":135,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":182408995,"gmtCreate":1623594402017,"gmtModify":1704206754370,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182408995","repostId":"2142024122","repostType":4,"repost":{"id":"2142024122","kind":"news","pubTimestamp":1623437876,"share":"https://ttm.financial/m/news/2142024122?lang=&edition=fundamental","pubTime":"2021-06-12 02:57","market":"us","language":"en","title":"Moderna Says No Link Between COVID-19 Jab And Heart Inflammation","url":"https://stock-news.laohu8.com/highlight/detail?id=2142024122","media":"Benzinga","summary":"Moderna Inc (NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and ca","content":"<p><img src=\"https://static.tigerbbs.com/d1f671326f56d69d77095c4224c4a60a\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Moderna Inc</b>&nbsp;(NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis,&nbsp;based on a review of safety data.</p>\n<p>The Centers for Disease Control and Prevention (CDC) has identified 216 cases of heart inflammation after the first dose of an mRNA shot and another 573 cases after the second dose,&nbsp;Bloomberg reported.</p>\n<p>The median age of people with myocarditis or pericarditis following the first dose was 30 and 24 in the second-dose cases. There were 475 cases among people under 30.</p>\n<p>U.S. public health advisers will meet later this month to discuss a potential link between messenger RNA technology-based COVID-19 shots and heart inflammation.</p>\n<p>The technology is used by Moderna’s vaccine and&nbsp;<b>Pfizer Inc&nbsp;</b>(NYSE: PFE) -&nbsp;<b><a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>&nbsp;</b>(NASDAQ: BNTX).</p>\n<p>Moderna said it “will continue to monitor these reports closely and is actively working with public health and regulatory authorities to further assess this issue.”</p>\n<p>Earlier this month,&nbsp;Israel’s Health Ministry also reportedly found&nbsp;a small number of heart inflammation cases, observed mainly in young men who received the Pfizer COVID-19 vaccine in Israel, were likely linked to their vaccination.</p>\n<p><b>Price Action:</b>&nbsp;MRNA shares are down 0.59% at $215.73 during the market session on the last check Friday.</p>\n<p></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Says No Link Between COVID-19 Jab And Heart Inflammation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Says No Link Between COVID-19 Jab And Heart Inflammation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 02:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-says-no-between-covid-185756853.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna Inc (NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis, based on a review of safety data.\nThe Centers for Disease ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-says-no-between-covid-185756853.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞","08237":"华星控股"},"source_url":"https://finance.yahoo.com/news/moderna-says-no-between-covid-185756853.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142024122","content_text":"Moderna Inc (NASDAQ: MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis, based on a review of safety data.\nThe Centers for Disease Control and Prevention (CDC) has identified 216 cases of heart inflammation after the first dose of an mRNA shot and another 573 cases after the second dose, Bloomberg reported.\nThe median age of people with myocarditis or pericarditis following the first dose was 30 and 24 in the second-dose cases. There were 475 cases among people under 30.\nU.S. public health advisers will meet later this month to discuss a potential link between messenger RNA technology-based COVID-19 shots and heart inflammation.\nThe technology is used by Moderna’s vaccine and Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX).\nModerna said it “will continue to monitor these reports closely and is actively working with public health and regulatory authorities to further assess this issue.”\nEarlier this month, Israel’s Health Ministry also reportedly found a small number of heart inflammation cases, observed mainly in young men who received the Pfizer COVID-19 vaccine in Israel, were likely linked to their vaccination.\nPrice Action: MRNA shares are down 0.59% at $215.73 during the market session on the last check Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182401763,"gmtCreate":1623594378352,"gmtModify":1704206754046,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182401763","repostId":"2142202519","repostType":4,"isVote":1,"tweetType":1,"viewCount":274,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":344511137,"gmtCreate":1618414768929,"gmtModify":1704710563027,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Heart]&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>[Heart]&nbsp;","text":"$Tiger Brokers(TIGR)$[Heart]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/344511137","isVote":1,"tweetType":1,"viewCount":586,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182457456,"gmtCreate":1623600952175,"gmtModify":1704206852956,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"[Miser]&nbsp;","listText":"[Miser]&nbsp;","text":"[Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182457456","repostId":"2142025622","repostType":4,"repost":{"id":"2142025622","kind":"news","pubTimestamp":1623442528,"share":"https://ttm.financial/m/news/2142025622?lang=&edition=fundamental","pubTime":"2021-06-12 04:15","market":"us","language":"en","title":"Biotech Finds Market Love at Last as Meme Traders, FDA Converge","url":"https://stock-news.laohu8.com/highlight/detail?id=2142025622","media":"Bloomberg","summary":"(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial","content":"<p><img src=\"https://static.tigerbbs.com/8cda5e1416d8765a6009019a2442b35a\" tg-width=\"1200\" tg-height=\"675\"></p>\n<p>(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. Now investors are taking a second look at the sector.</p>\n<p>With biotech having trailed the broader market for the past three months and chock full of companies that have been the focus of short sellers, it was catnip for the Reddit crowd. Indeed, the price action wrought havoc across the health-care sector after shorts lost over $465 million on Clover Health Investments Corp. in a single day as the stock nearly doubled.</p>\n<p>The moves weren’t just about amateur traders or punishing the shorts. Specialists who live and breathe biotech received two of three critical updates that have been hailed as the impetus for a broad return of investor interest. That includes approval from the Food and Drug Administration of an Alzheimer’s disease drug from Biogen Inc.</p>\n<p>“One of the clouds overhanging the sector went away this week, it’s a very good sign,” Brad Loncar, chief executive officer of Loncar Investments, said of the FDA decision.</p>\n<p>Monday’s decision by the FDA to approve Aduhelm, the first new medicine for the disease in decades, came despite mixed clinical trials, stunning analysts and buoying the sector. More than 15 million shares in the $11 billion <a href=\"https://laohu8.com/S/EEME\">iShares</a> Nasdaq Biotechnology ETF (IBB) changed hands, the highest daily level since June 2017. The index ended the week up 6%.</p>\n<p>It wasn’t all good news for these drugmakers. Aduhelm’s $56,000 a year price tag and a setback for Vertex Pharmaceuticals Inc. tempered the rally. The cost of the Biogen drug renewed concern about a regulatory clampdown on pricing, while Vertex announced that it had halted development of a liver disease treatment that the company said was unlikely to have a clinical benefit for patients. Shares of the drug developer plunged 11% on Friday and it’s the worst performer among large-cap biotechs, falling 18% so far this year.</p>\n<p>There’s <a href=\"https://laohu8.com/S/AONE\">one</a> more key readout biotech investors are waiting on: results from a trial in major depression from Biogen and its partner <a href=\"https://laohu8.com/S/SAGE\">Sage Therapeutics</a> Inc. With a win for Biogen and a loss for Vertex, the Biogen-Sage results could very well determine which direction biotech goes next, according to RBC analyst Brian Abrahams. The data are expected by the end of June.</p>\n<p>A recent Goldman Sachs survey of 75 investors at the bank’s health-care conference highlights the ongoing uncertainty, with 47% saying the sector would outperform over the second half of the year while the rest were evenly split between expecting health stocks to underperform or move in-line with the broader market.</p>\n<p><b>M&amp;A Hopes</b></p>\n<p>Vertex’s recent failure also came with a silver lining: the potential for a deal to bolster its pipeline. “Management has signaled a new openness to later-stage deals, and the shelving of VX-864 may now force its hand,” Bloomberg Intelligence analyst Marc Engelsgjerd wrote in a note.</p>\n<p>The pace of deals in the first half can determine the direction of biotechs for the rest of 2021, with years that start off with five or more deals over $500 million usually driving the outperformance of nearly 4% for the Nasdaq Biotech index, according to JPMorgan’s analysis.</p>\n<p>As biotech specialists weighed the catalysts for further gains, an 86% jump for Chamath Palihapitiya-backed health insurer Clover drove interest toward once high-flying biotechs with highly shorted floats and mediocre analyst ratings. <a href=\"https://laohu8.com/S/INO\">Inovio Pharmaceuticals Inc</a>., which recently lost U.S. government funding for its Covid shot, and <a href=\"https://laohu8.com/S/CLVS\">Clovis Oncology</a> Inc., a fallen former M&amp;A target with a disappointing cancer drug, popped this week as day traders targeted short-squeeze candidates.</p>\n<p>Retail traders have also been driving triple-digit and even quadruple-digit gains in obscure biotech names like Ocugen Inc., a drug developer with plans to bring a Covid-19 vaccine to the U.S., and <a href=\"https://laohu8.com/S/SAVA\">Cassava Sciences Inc</a>., a 20-year old biotech whose main product isn’t yet in the final stages of testing.</p>\n<p>Loncar at least is unfazed by biotechs joining the meme parade. “Professionals understand what the true intrinsic value of a biotech is,” he said in an interview. “Unlike GameStop or AMC, a biotech either has good science or it doesn’t.”</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biotech Finds Market Love at Last as Meme Traders, FDA Converge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiotech Finds Market Love at Last as Meme Traders, FDA Converge\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-12 04:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRTX":"福泰制药","BIIB":"渤健公司"},"source_url":"https://finance.yahoo.com/news/biotech-finds-market-love-last-201528495.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2142025622","content_text":"(Bloomberg) -- Unloved biotech stocks posted the best week since November, fueled by a controversial regulatory decision and a legion of Reddit fans, burning a bunch of short sellers along the way. Now investors are taking a second look at the sector.\nWith biotech having trailed the broader market for the past three months and chock full of companies that have been the focus of short sellers, it was catnip for the Reddit crowd. Indeed, the price action wrought havoc across the health-care sector after shorts lost over $465 million on Clover Health Investments Corp. in a single day as the stock nearly doubled.\nThe moves weren’t just about amateur traders or punishing the shorts. Specialists who live and breathe biotech received two of three critical updates that have been hailed as the impetus for a broad return of investor interest. That includes approval from the Food and Drug Administration of an Alzheimer’s disease drug from Biogen Inc.\n“One of the clouds overhanging the sector went away this week, it’s a very good sign,” Brad Loncar, chief executive officer of Loncar Investments, said of the FDA decision.\nMonday’s decision by the FDA to approve Aduhelm, the first new medicine for the disease in decades, came despite mixed clinical trials, stunning analysts and buoying the sector. More than 15 million shares in the $11 billion iShares Nasdaq Biotechnology ETF (IBB) changed hands, the highest daily level since June 2017. The index ended the week up 6%.\nIt wasn’t all good news for these drugmakers. Aduhelm’s $56,000 a year price tag and a setback for Vertex Pharmaceuticals Inc. tempered the rally. The cost of the Biogen drug renewed concern about a regulatory clampdown on pricing, while Vertex announced that it had halted development of a liver disease treatment that the company said was unlikely to have a clinical benefit for patients. Shares of the drug developer plunged 11% on Friday and it’s the worst performer among large-cap biotechs, falling 18% so far this year.\nThere’s one more key readout biotech investors are waiting on: results from a trial in major depression from Biogen and its partner Sage Therapeutics Inc. With a win for Biogen and a loss for Vertex, the Biogen-Sage results could very well determine which direction biotech goes next, according to RBC analyst Brian Abrahams. The data are expected by the end of June.\nA recent Goldman Sachs survey of 75 investors at the bank’s health-care conference highlights the ongoing uncertainty, with 47% saying the sector would outperform over the second half of the year while the rest were evenly split between expecting health stocks to underperform or move in-line with the broader market.\nM&A Hopes\nVertex’s recent failure also came with a silver lining: the potential for a deal to bolster its pipeline. “Management has signaled a new openness to later-stage deals, and the shelving of VX-864 may now force its hand,” Bloomberg Intelligence analyst Marc Engelsgjerd wrote in a note.\nThe pace of deals in the first half can determine the direction of biotechs for the rest of 2021, with years that start off with five or more deals over $500 million usually driving the outperformance of nearly 4% for the Nasdaq Biotech index, according to JPMorgan’s analysis.\nAs biotech specialists weighed the catalysts for further gains, an 86% jump for Chamath Palihapitiya-backed health insurer Clover drove interest toward once high-flying biotechs with highly shorted floats and mediocre analyst ratings. Inovio Pharmaceuticals Inc., which recently lost U.S. government funding for its Covid shot, and Clovis Oncology Inc., a fallen former M&A target with a disappointing cancer drug, popped this week as day traders targeted short-squeeze candidates.\nRetail traders have also been driving triple-digit and even quadruple-digit gains in obscure biotech names like Ocugen Inc., a drug developer with plans to bring a Covid-19 vaccine to the U.S., and Cassava Sciences Inc., a 20-year old biotech whose main product isn’t yet in the final stages of testing.\nLoncar at least is unfazed by biotechs joining the meme parade. “Professionals understand what the true intrinsic value of a biotech is,” he said in an interview. “Unlike GameStop or AMC, a biotech either has good science or it doesn’t.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":385,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":182402944,"gmtCreate":1623594593988,"gmtModify":1704206756152,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182402944","repostId":"1131879907","repostType":4,"repost":{"id":"1131879907","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623411896,"share":"https://ttm.financial/m/news/1131879907?lang=&edition=fundamental","pubTime":"2021-06-11 19:44","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1131879907","media":"Tiger Newspress","summary":"S&P 500 looks to add to Thursday's record close.\nMeme stocks get some relief after hitting a wall.\nB","content":"<ul>\n <li>S&amp;P 500 looks to add to Thursday's record close.</li>\n <li>Meme stocks get some relief after hitting a wall.</li>\n <li>Blockchain stocks rally in premarket trading.</li>\n <li>Airline stocks rally in premarket trading.</li>\n <li>EV stocks rally in premarket trading.</li>\n</ul>\n<p>(June 11)&nbsp;U.S. stock futures traded slightly higher in early pre-market trade after the S&amp;P 500 index jumped to a new high in the previous session following data on consumer price inflation and jobless claims. Investors are awaiting earnings results from&nbsp;<b>Cheetah Mobile</b>&nbsp;and&nbsp;<b>Azure Power Global</b>.</p>\n<p>The University of Michigan's consumer sentiment index for June is scheduled for release at 10:00 a.m. ET. The consumer sentiment index dropped over 5 points to 82.9 in May due to rising inflation expectations. Analysts, however, expect June's preliminary reading to rise slightly to 84.</p>\n<p>At 7:58 a.m. ET, Dow e-minis were up 73 points, or 0.21%, S&amp;P 500 e-minis were up 6.5 points, or 0.15%, and Nasdaq 100 e-minis were up 28 points, or 0.20%.</p>\n<p><img src=\"https://static.tigerbbs.com/18bcc00946e29ba65e1d29af6ef12226\" tg-width=\"1242\" tg-height=\"507\" referrerpolicy=\"no-referrer\">Meme stocks were getting some relief early Friday after hitting a wall Thursday. Shares of GameStop, which tanked 27% on Thursday, rose 6% in the premarket. GameStop investors seemed to be running for the exits Thursday, one day after the video game retailer announced the appointments of two former Amazon executives as CEO and CFO and said it may sell as many as 5 million additional shares to raise money. GameStop — off about 50% from its $483 per share all-time high in January — remained up nearly 1,100% in 2021. Last week's big winner, AMC Entertainment, rose 4% in Friday's premarket after closing down 13% on Thursday. The stock — down more than 40% from last week's all-time high of $72.62 — was still up 1,900% this year.</p>\n<p><b>Stocks making the biggest moves in the premarket: Snowflake, Vertex Pharmaceuticals, Chewy &amp; more</b></p>\n<p><b>1)&nbsp;Snowflake(SNOW)</b> – Snowflake shares fell 3.7% in premarket trading, following the cloud computing company’s presentation of financial targets at its Investor Day meeting. Snowflake set a target of reaching $10 billion in annual product revenue by 2029, compared to $554 million in its fiscal year that ended in January.</p>\n<p><b>2)&nbsp;Vertex Pharmaceuticals(VRTX)</b> – The drugmaker halted development of an experimental drug designed to treat a rare genetic disease called AAT Deficiency. Vertex said the drug raised levels of a deficient protein, but not enough to provide a substantial benefit. Vertex plunged 13.9% in the premarket.</p>\n<p><b>3)&nbsp;Chewy(CHWY) </b>– Chewy earned 9 cents per share for its latest quarter, compared to consensus forecasts for a 3 cents per share loss. The pet products retailer's revenue also beat estimates and gave an upbeat revenue outlook. Chewy also warned of labor shortages and supply chain issues that are impacting product availability.</p>\n<p><b>4)&nbsp;Dave &amp; Buster's(PLAY) </b>– Dave &amp; Buster's reported a surprise profit for its first quarter, with earnings of 40 cents per share. Analysts had predicted a loss of 16 cents per share for the restaurant chain. Dave &amp; Buster's said the recovery in its business has continued through the first part of the current quarter, and its shares jumped 5.5% in premarket action.</p>\n<p><b>5)&nbsp;Royal Caribbean(RCL)</b> – Royal Caribbean’s Celebrity line said two passengers aboard its Millennium cruise shiptested positive for Covid-19. The passengers – who were traveling together – are asymptomatic and have been isolated, and the cruise line is currently conducting contact tracing. Royal Caribbean lost 1.3% in premarket trading.</p>\n<p><b>6)&nbsp;Biogen(BIIB)</b> – Biogen added 1.4% in the premarket after UBS upgraded the drug maker’s stock to “buy” from “neutral,” and Bernstein raised its rating to “outperform” from “market perform.” Both firms base their upgrades on the potential sales bump from the Food and Drug Administration’s approval this week of Alzheimer’s disease treatment Aduhelm.</p>\n<p><b>7)&nbsp;AMC Entertainment(AMC),GameStop(GME),Clover Health(CLOV)</b> – These “meme stocks” continue to be volatile, with AMC surging 8% in the premarket, GameStop jumping 5.7% and Clover Health up 3%.</p>\n<p><b>8)&nbsp;Tesla(TSLA) </b>– Teslaunveiled its Model S Plaidat an event held at its Fremont, California factory. The new high-end version of its Model S sells for just under $130,000. Separately, Goldman Sachs reiterated its “buy” rating on the stock.</p>\n<p><b>9)&nbsp;American Airlines(AAL)</b> – American Airlines is investing $25 million in electric flying taxi startup Vertical Aerospace. American said it planned to buy up to 250 of the electric aircraft, which are set for an initial test flight later this year.</p>\n<p><b>10)&nbsp;Callaway Golf(ELY)</b> – Callaway Golf will replaceGrubHub(GRUB) in the S&amp;P MidCap 400 index, effective prior to the opening of trading on June 15. GrubHub is in the process of being acquired by British firm Just Eat Takeaway. Callaway – a leading maker of golf clubs and other golf products – will be replaced in the S&amp;P SmallCap 600 byApollo Medical(AMEH). Callaway slid 3.7% in premarket trading, while Apollo surged 11.9%.</p>\n<p><b>11)&nbsp;Livent(LTHM)</b> – The lithium power specialist’s shares fell 2% in the premarket after announcing a public offering of 13 million shares at $17.50 per share. Livent plans to use the proceeds for general corporate purposes, repaying debt, and boosting capital spending.</p>\n<p><b>12)&nbsp;Monday.com(MNDY)</b> – The Israel-based maker of work management software is on watch ahead of its second day of trading, after pricing its initial public offering at $155 per share and closing Thursday at $178.87.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-11 19:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>S&amp;P 500 looks to add to Thursday's record close.</li>\n <li>Meme stocks get some relief after hitting a wall.</li>\n <li>Blockchain stocks rally in premarket trading.</li>\n <li>Airline stocks rally in premarket trading.</li>\n <li>EV stocks rally in premarket trading.</li>\n</ul>\n<p>(June 11)&nbsp;U.S. stock futures traded slightly higher in early pre-market trade after the S&amp;P 500 index jumped to a new high in the previous session following data on consumer price inflation and jobless claims. Investors are awaiting earnings results from&nbsp;<b>Cheetah Mobile</b>&nbsp;and&nbsp;<b>Azure Power Global</b>.</p>\n<p>The University of Michigan's consumer sentiment index for June is scheduled for release at 10:00 a.m. ET. The consumer sentiment index dropped over 5 points to 82.9 in May due to rising inflation expectations. Analysts, however, expect June's preliminary reading to rise slightly to 84.</p>\n<p>At 7:58 a.m. ET, Dow e-minis were up 73 points, or 0.21%, S&amp;P 500 e-minis were up 6.5 points, or 0.15%, and Nasdaq 100 e-minis were up 28 points, or 0.20%.</p>\n<p><img src=\"https://static.tigerbbs.com/18bcc00946e29ba65e1d29af6ef12226\" tg-width=\"1242\" tg-height=\"507\" referrerpolicy=\"no-referrer\">Meme stocks were getting some relief early Friday after hitting a wall Thursday. Shares of GameStop, which tanked 27% on Thursday, rose 6% in the premarket. GameStop investors seemed to be running for the exits Thursday, one day after the video game retailer announced the appointments of two former Amazon executives as CEO and CFO and said it may sell as many as 5 million additional shares to raise money. GameStop — off about 50% from its $483 per share all-time high in January — remained up nearly 1,100% in 2021. Last week's big winner, AMC Entertainment, rose 4% in Friday's premarket after closing down 13% on Thursday. The stock — down more than 40% from last week's all-time high of $72.62 — was still up 1,900% this year.</p>\n<p><b>Stocks making the biggest moves in the premarket: Snowflake, Vertex Pharmaceuticals, Chewy &amp; more</b></p>\n<p><b>1)&nbsp;Snowflake(SNOW)</b> – Snowflake shares fell 3.7% in premarket trading, following the cloud computing company’s presentation of financial targets at its Investor Day meeting. Snowflake set a target of reaching $10 billion in annual product revenue by 2029, compared to $554 million in its fiscal year that ended in January.</p>\n<p><b>2)&nbsp;Vertex Pharmaceuticals(VRTX)</b> – The drugmaker halted development of an experimental drug designed to treat a rare genetic disease called AAT Deficiency. Vertex said the drug raised levels of a deficient protein, but not enough to provide a substantial benefit. Vertex plunged 13.9% in the premarket.</p>\n<p><b>3)&nbsp;Chewy(CHWY) </b>– Chewy earned 9 cents per share for its latest quarter, compared to consensus forecasts for a 3 cents per share loss. The pet products retailer's revenue also beat estimates and gave an upbeat revenue outlook. Chewy also warned of labor shortages and supply chain issues that are impacting product availability.</p>\n<p><b>4)&nbsp;Dave &amp; Buster's(PLAY) </b>– Dave &amp; Buster's reported a surprise profit for its first quarter, with earnings of 40 cents per share. Analysts had predicted a loss of 16 cents per share for the restaurant chain. Dave &amp; Buster's said the recovery in its business has continued through the first part of the current quarter, and its shares jumped 5.5% in premarket action.</p>\n<p><b>5)&nbsp;Royal Caribbean(RCL)</b> – Royal Caribbean’s Celebrity line said two passengers aboard its Millennium cruise shiptested positive for Covid-19. The passengers – who were traveling together – are asymptomatic and have been isolated, and the cruise line is currently conducting contact tracing. Royal Caribbean lost 1.3% in premarket trading.</p>\n<p><b>6)&nbsp;Biogen(BIIB)</b> – Biogen added 1.4% in the premarket after UBS upgraded the drug maker’s stock to “buy” from “neutral,” and Bernstein raised its rating to “outperform” from “market perform.” Both firms base their upgrades on the potential sales bump from the Food and Drug Administration’s approval this week of Alzheimer’s disease treatment Aduhelm.</p>\n<p><b>7)&nbsp;AMC Entertainment(AMC),GameStop(GME),Clover Health(CLOV)</b> – These “meme stocks” continue to be volatile, with AMC surging 8% in the premarket, GameStop jumping 5.7% and Clover Health up 3%.</p>\n<p><b>8)&nbsp;Tesla(TSLA) </b>– Teslaunveiled its Model S Plaidat an event held at its Fremont, California factory. The new high-end version of its Model S sells for just under $130,000. Separately, Goldman Sachs reiterated its “buy” rating on the stock.</p>\n<p><b>9)&nbsp;American Airlines(AAL)</b> – American Airlines is investing $25 million in electric flying taxi startup Vertical Aerospace. American said it planned to buy up to 250 of the electric aircraft, which are set for an initial test flight later this year.</p>\n<p><b>10)&nbsp;Callaway Golf(ELY)</b> – Callaway Golf will replaceGrubHub(GRUB) in the S&amp;P MidCap 400 index, effective prior to the opening of trading on June 15. GrubHub is in the process of being acquired by British firm Just Eat Takeaway. Callaway – a leading maker of golf clubs and other golf products – will be replaced in the S&amp;P SmallCap 600 byApollo Medical(AMEH). Callaway slid 3.7% in premarket trading, while Apollo surged 11.9%.</p>\n<p><b>11)&nbsp;Livent(LTHM)</b> – The lithium power specialist’s shares fell 2% in the premarket after announcing a public offering of 13 million shares at $17.50 per share. Livent plans to use the proceeds for general corporate purposes, repaying debt, and boosting capital spending.</p>\n<p><b>12)&nbsp;Monday.com(MNDY)</b> – The Israel-based maker of work management software is on watch ahead of its second day of trading, after pricing its initial public offering at $155 per share and closing Thursday at $178.87.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131879907","content_text":"S&P 500 looks to add to Thursday's record close.\nMeme stocks get some relief after hitting a wall.\nBlockchain stocks rally in premarket trading.\nAirline stocks rally in premarket trading.\nEV stocks rally in premarket trading.\n\n(June 11) U.S. stock futures traded slightly higher in early pre-market trade after the S&P 500 index jumped to a new high in the previous session following data on consumer price inflation and jobless claims. Investors are awaiting earnings results from Cheetah Mobile and Azure Power Global.\nThe University of Michigan's consumer sentiment index for June is scheduled for release at 10:00 a.m. ET. The consumer sentiment index dropped over 5 points to 82.9 in May due to rising inflation expectations. Analysts, however, expect June's preliminary reading to rise slightly to 84.\nAt 7:58 a.m. ET, Dow e-minis were up 73 points, or 0.21%, S&P 500 e-minis were up 6.5 points, or 0.15%, and Nasdaq 100 e-minis were up 28 points, or 0.20%.\nMeme stocks were getting some relief early Friday after hitting a wall Thursday. Shares of GameStop, which tanked 27% on Thursday, rose 6% in the premarket. GameStop investors seemed to be running for the exits Thursday, one day after the video game retailer announced the appointments of two former Amazon executives as CEO and CFO and said it may sell as many as 5 million additional shares to raise money. GameStop — off about 50% from its $483 per share all-time high in January — remained up nearly 1,100% in 2021. Last week's big winner, AMC Entertainment, rose 4% in Friday's premarket after closing down 13% on Thursday. The stock — down more than 40% from last week's all-time high of $72.62 — was still up 1,900% this year.\nStocks making the biggest moves in the premarket: Snowflake, Vertex Pharmaceuticals, Chewy & more\n1) Snowflake(SNOW) – Snowflake shares fell 3.7% in premarket trading, following the cloud computing company’s presentation of financial targets at its Investor Day meeting. Snowflake set a target of reaching $10 billion in annual product revenue by 2029, compared to $554 million in its fiscal year that ended in January.\n2) Vertex Pharmaceuticals(VRTX) – The drugmaker halted development of an experimental drug designed to treat a rare genetic disease called AAT Deficiency. Vertex said the drug raised levels of a deficient protein, but not enough to provide a substantial benefit. Vertex plunged 13.9% in the premarket.\n3) Chewy(CHWY) – Chewy earned 9 cents per share for its latest quarter, compared to consensus forecasts for a 3 cents per share loss. The pet products retailer's revenue also beat estimates and gave an upbeat revenue outlook. Chewy also warned of labor shortages and supply chain issues that are impacting product availability.\n4) Dave & Buster's(PLAY) – Dave & Buster's reported a surprise profit for its first quarter, with earnings of 40 cents per share. Analysts had predicted a loss of 16 cents per share for the restaurant chain. Dave & Buster's said the recovery in its business has continued through the first part of the current quarter, and its shares jumped 5.5% in premarket action.\n5) Royal Caribbean(RCL) – Royal Caribbean’s Celebrity line said two passengers aboard its Millennium cruise shiptested positive for Covid-19. The passengers – who were traveling together – are asymptomatic and have been isolated, and the cruise line is currently conducting contact tracing. Royal Caribbean lost 1.3% in premarket trading.\n6) Biogen(BIIB) – Biogen added 1.4% in the premarket after UBS upgraded the drug maker’s stock to “buy” from “neutral,” and Bernstein raised its rating to “outperform” from “market perform.” Both firms base their upgrades on the potential sales bump from the Food and Drug Administration’s approval this week of Alzheimer’s disease treatment Aduhelm.\n7) AMC Entertainment(AMC),GameStop(GME),Clover Health(CLOV) – These “meme stocks” continue to be volatile, with AMC surging 8% in the premarket, GameStop jumping 5.7% and Clover Health up 3%.\n8) Tesla(TSLA) – Teslaunveiled its Model S Plaidat an event held at its Fremont, California factory. The new high-end version of its Model S sells for just under $130,000. Separately, Goldman Sachs reiterated its “buy” rating on the stock.\n9) American Airlines(AAL) – American Airlines is investing $25 million in electric flying taxi startup Vertical Aerospace. American said it planned to buy up to 250 of the electric aircraft, which are set for an initial test flight later this year.\n10) Callaway Golf(ELY) – Callaway Golf will replaceGrubHub(GRUB) in the S&P MidCap 400 index, effective prior to the opening of trading on June 15. GrubHub is in the process of being acquired by British firm Just Eat Takeaway. Callaway – a leading maker of golf clubs and other golf products – will be replaced in the S&P SmallCap 600 byApollo Medical(AMEH). Callaway slid 3.7% in premarket trading, while Apollo surged 11.9%.\n11) Livent(LTHM) – The lithium power specialist’s shares fell 2% in the premarket after announcing a public offering of 13 million shares at $17.50 per share. Livent plans to use the proceeds for general corporate purposes, repaying debt, and boosting capital spending.\n12) Monday.com(MNDY) – The Israel-based maker of work management software is on watch ahead of its second day of trading, after pricing its initial public offering at $155 per share and closing Thursday at $178.87.","news_type":1},"isVote":1,"tweetType":1,"viewCount":376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":348806858,"gmtCreate":1617899269374,"gmtModify":1704704634850,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348806858","repostId":"1162076415","repostType":4,"isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314683216,"gmtCreate":1612344410635,"gmtModify":1704869948663,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/314683216","repostId":"2108570747","repostType":2,"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314696917,"gmtCreate":1612341635839,"gmtModify":1704869911242,"author":{"id":"3568939926708961","authorId":"3568939926708961","name":"KennethNg","avatar":"https://static.tigerbbs.com/fb21175df05da17d9f0a2df034ac7468","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3568939926708961","authorIdStr":"3568939926708961"},"themes":[],"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/314696917","repostId":"1163068052","repostType":2,"repost":{"id":"1163068052","kind":"news","pubTimestamp":1612335216,"share":"https://ttm.financial/m/news/1163068052?lang=&edition=fundamental","pubTime":"2021-02-03 14:53","market":"us","language":"en","title":"Elon Musk's banter with Robinhood CEO triggers stampede for Clubhouse app","url":"https://stock-news.laohu8.com/highlight/detail?id=1163068052","media":"reuters","summary":"(Reuters) - A surprise chat between tech billionaire Elon Musk and Robinhood CEO Vlad Tenev on new a","content":"<p>(Reuters) - A surprise chat between tech billionaire Elon Musk and Robinhood CEO Vlad Tenev on new audio-based social network Clubhouse has helped propel the app to the top of the startup charts and sparked a scramble for invitations to the exclusive service.</p>\n<p>The interaction between the two entrepreneurs on the platform on Sunday came amid intense interest in news around Robinhood, the online brokerage caught up in a wild stockmarket battle between retail investors and big Wall Street funds.</p>\n<p>Demand for invitations to the less-than-a-year-old service -- members get to invite a limited number of friends during its pre-launch period -- is so hot, a market for them has grown on platforms like Reddit, eBay, and Craigslist.</p>\n<p>In China, invitations are being sold on Alibaba’s second-hand market place Idle Fish, even though Clubhouse isn’t available in Apple’s app store in that country.</p>\n<p>In Japan investors, tech workers and the media have swarmed the service.</p>\n<p>As of Tuesday, data analytics firm Sensor Tower said there were about 3.6 million installs worldwide for the app--only available on Apple’s iPhone--with 1.1 million of them coming in the last six days.</p>\n<p>Investors were so eager for a piece of the action that at one point on Monday they pushed up shares in Clubhouse Media Group [CMGR.PK], a completely unrelated stock, by 117%.</p>\n<p>Chinese tech firm Agora Inc, listed on Nasdaq, saw its shares jump 30% on media reports that it may be a technology partner to Clubhouse. Agora declined to comment while a Clubhouse spokeswoman declined to comment on questions about technology partners.</p>\n<p>The San Francisco-based company’s latest round of financing in Jan. 24 valued the company at $1 billion, a source familiar with the matter said. The funding was led by Andreessen Horowitz, a leading Silicon Valley venture capital firm.</p>\n<p>CLUBBY</p>\n<p>Amid the buzz, Clubhouse has also drawn backlash from those who criticize the closed-door nature of chats like the one between Musk and Tenev.</p>\n<p>Jessica Lessin, editor-in-chief of tech news outlet The Information tweeted that Marc Andreessen, a founding partner of Andreessen Horowitz, which also backs Robinhood, had blocked many reporters from listening in on Musk’s talk.</p>\n<p>The chat between Musk and Tenev took place on a regular Clubhouse event called “The Good Time Show.”</p>\n<p>Andreessen Horowitz didn’t reply to Reuters’ request for comment on this issue.</p>\n<p>However, Clubhouse CEO Paul Davidson told Bloomberg TV on Monday event hosts could choose who is allowed to listen, underscoring concerns about the clubby nature of the app.</p>\n<p>Andreessen Horowitz separately said in a blog in January that it was launching new “media property,” adding to its already active podcasting and blogging activities.</p>\n<p>Clubhouse aspires to make the app widely available, and foresees business opportunities in subscriptions or tickets to events like the one Musk starred in.</p>\n<p>It will have to contend with moderating the kind of site abuses, from hate speech to harassment, that major social media platforms face. Clubhouse has been criticized over reports of harassment and hate speech in its rooms, some of which are private and some public.</p>\n<p>A spokeswoman for the app said it has already banned some individual users from the platform for violating its rules but declined to share more details.</p>\n<p>The company has said it does not allow racism, hate speech, sexism and abuse on the network, though it says it does allow “general rudeness.” It has said users who found clubs on the app will be able to set rules for their communities.</p>\n<p>The Clubhouse spokeswoman said it currently has about 10 staff. The company has said it is investing in tools that detect and prevent abuse as well as features for users to moderate.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk's banter with Robinhood CEO triggers stampede for Clubhouse app</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk's banter with Robinhood CEO triggers stampede for Clubhouse app\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-03 14:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/us-social-media-clubhouse/elon-musks-banter-with-robinhood-ceo-triggers-stampede-for-clubhouse-app-idUSKBN2A30R6?il=0><strong>reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - A surprise chat between tech billionaire Elon Musk and Robinhood CEO Vlad Tenev on new audio-based social network Clubhouse has helped propel the app to the top of the startup charts and ...</p>\n\n<a href=\"https://www.reuters.com/article/us-social-media-clubhouse/elon-musks-banter-with-robinhood-ceo-triggers-stampede-for-clubhouse-app-idUSKBN2A30R6?il=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.reuters.com/article/us-social-media-clubhouse/elon-musks-banter-with-robinhood-ceo-triggers-stampede-for-clubhouse-app-idUSKBN2A30R6?il=0","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163068052","content_text":"(Reuters) - A surprise chat between tech billionaire Elon Musk and Robinhood CEO Vlad Tenev on new audio-based social network Clubhouse has helped propel the app to the top of the startup charts and sparked a scramble for invitations to the exclusive service.\nThe interaction between the two entrepreneurs on the platform on Sunday came amid intense interest in news around Robinhood, the online brokerage caught up in a wild stockmarket battle between retail investors and big Wall Street funds.\nDemand for invitations to the less-than-a-year-old service -- members get to invite a limited number of friends during its pre-launch period -- is so hot, a market for them has grown on platforms like Reddit, eBay, and Craigslist.\nIn China, invitations are being sold on Alibaba’s second-hand market place Idle Fish, even though Clubhouse isn’t available in Apple’s app store in that country.\nIn Japan investors, tech workers and the media have swarmed the service.\nAs of Tuesday, data analytics firm Sensor Tower said there were about 3.6 million installs worldwide for the app--only available on Apple’s iPhone--with 1.1 million of them coming in the last six days.\nInvestors were so eager for a piece of the action that at one point on Monday they pushed up shares in Clubhouse Media Group [CMGR.PK], a completely unrelated stock, by 117%.\nChinese tech firm Agora Inc, listed on Nasdaq, saw its shares jump 30% on media reports that it may be a technology partner to Clubhouse. Agora declined to comment while a Clubhouse spokeswoman declined to comment on questions about technology partners.\nThe San Francisco-based company’s latest round of financing in Jan. 24 valued the company at $1 billion, a source familiar with the matter said. The funding was led by Andreessen Horowitz, a leading Silicon Valley venture capital firm.\nCLUBBY\nAmid the buzz, Clubhouse has also drawn backlash from those who criticize the closed-door nature of chats like the one between Musk and Tenev.\nJessica Lessin, editor-in-chief of tech news outlet The Information tweeted that Marc Andreessen, a founding partner of Andreessen Horowitz, which also backs Robinhood, had blocked many reporters from listening in on Musk’s talk.\nThe chat between Musk and Tenev took place on a regular Clubhouse event called “The Good Time Show.”\nAndreessen Horowitz didn’t reply to Reuters’ request for comment on this issue.\nHowever, Clubhouse CEO Paul Davidson told Bloomberg TV on Monday event hosts could choose who is allowed to listen, underscoring concerns about the clubby nature of the app.\nAndreessen Horowitz separately said in a blog in January that it was launching new “media property,” adding to its already active podcasting and blogging activities.\nClubhouse aspires to make the app widely available, and foresees business opportunities in subscriptions or tickets to events like the one Musk starred in.\nIt will have to contend with moderating the kind of site abuses, from hate speech to harassment, that major social media platforms face. Clubhouse has been criticized over reports of harassment and hate speech in its rooms, some of which are private and some public.\nA spokeswoman for the app said it has already banned some individual users from the platform for violating its rules but declined to share more details.\nThe company has said it does not allow racism, hate speech, sexism and abuse on the network, though it says it does allow “general rudeness.” It has said users who found clubs on the app will be able to set rules for their communities.\nThe Clubhouse spokeswoman said it currently has about 10 staff. The company has said it is investing in tools that detect and prevent abuse as well as features for users to moderate.","news_type":1},"isVote":1,"tweetType":1,"viewCount":135,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}